Platform products for self-injection

Ypsomed's platform portfolio offers advanced self-injection devices, including reusable and prefilled pens, autoinjectors, wearable injectors, and digital health solutions. Each platform is engineered in Switzerland for fast, efficient customisation, significantly reducing time to market and minimising development risks by using pre-developed, proven technologies. The adaptable manufacturing processes support both small-scale clinical trials and high-volume commercial production, ensuring scalability as needed. This flexibility enables an efficient transition from development to market, providing reliable, safe drug delivery solutions at every stage.